BG62325B1 - Фармацевтичен състав за лечение на глаукома - Google Patents

Фармацевтичен състав за лечение на глаукома Download PDF

Info

Publication number
BG62325B1
BG62325B1 BG99213A BG9921394A BG62325B1 BG 62325 B1 BG62325 B1 BG 62325B1 BG 99213 A BG99213 A BG 99213A BG 9921394 A BG9921394 A BG 9921394A BG 62325 B1 BG62325 B1 BG 62325B1
Authority
BG
Bulgaria
Prior art keywords
amosulalol hydrochloride
eye
glaucoma
amosulalol
hydrochloride
Prior art date
Application number
BG99213A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG99213A (bg
Inventor
Takahiro Ogawa
Takaaki Deguchi
Yoshifumi Ikejiry
Katsuhiro Inada
Original Assignee
Senju Pharmaceutical Co.
Yamanouchi Pharmaceutical Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co., Yamanouchi Pharmaceutical Co. filed Critical Senju Pharmaceutical Co.
Publication of BG99213A publication Critical patent/BG99213A/bg
Publication of BG62325B1 publication Critical patent/BG62325B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BG99213A 1992-05-22 1994-11-28 Фармацевтичен състав за лечение на глаукома BG62325B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13082892 1992-05-22
PCT/JP1993/000654 WO1993024121A1 (en) 1992-05-22 1993-05-19 Remedy for glaucoma

Publications (2)

Publication Number Publication Date
BG99213A BG99213A (bg) 1995-08-28
BG62325B1 true BG62325B1 (bg) 1999-08-31

Family

ID=15043659

Family Applications (1)

Application Number Title Priority Date Filing Date
BG99213A BG62325B1 (bg) 1992-05-22 1994-11-28 Фармацевтичен състав за лечение на глаукома

Country Status (14)

Country Link
US (1) US5663205A (de)
EP (1) EP0642789B1 (de)
KR (1) KR100253515B1 (de)
CN (1) CN1080849A (de)
AT (1) ATE185070T1 (de)
BG (1) BG62325B1 (de)
BR (1) BR9306399A (de)
CA (1) CA2136321A1 (de)
DE (1) DE69326610T2 (de)
ES (1) ES2137260T3 (de)
HU (1) HUT71123A (de)
RU (1) RU2102069C1 (de)
TW (1) TW219930B (de)
WO (1) WO1993024121A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737494B1 (fr) * 1995-08-04 1997-08-29 Synthelabo Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
ID19891A (id) * 1996-08-02 1998-08-20 Senju Pharma Co Komposisi gangguan peredaran anti-okular
US6379688B2 (en) 1997-02-28 2002-04-30 Senju Pharmaceutical Co., Ltd. Preservative for emulsion and emulsion containing same
US6036946A (en) 1997-12-24 2000-03-14 Shaklee Corporation Methods for protecting skin from damaging effects of ultraviolet light
US6146664A (en) * 1998-07-10 2000-11-14 Shaklee Corporation Stable topical ascorbic acid compositions
AU757896B2 (en) * 1998-09-02 2003-03-13 Allergan, Inc. Preserved cyclodextrin-containing compositions
US7708711B2 (en) 2000-04-14 2010-05-04 Glaukos Corporation Ocular implant with therapeutic agents and methods thereof
US7867186B2 (en) 2002-04-08 2011-01-11 Glaukos Corporation Devices and methods for treatment of ocular disorders
US7431710B2 (en) 2002-04-08 2008-10-07 Glaukos Corporation Ocular implants with anchors and methods thereof
EP1977724A1 (de) 2001-04-07 2008-10-08 Glaukos Corporation System zur Behandlung von Augenstörungen
US7678065B2 (en) 2001-05-02 2010-03-16 Glaukos Corporation Implant with intraocular pressure sensor for glaucoma treatment
AU2002305400A1 (en) 2001-05-03 2002-11-18 Glaukos Corporation Medical device and methods of use for glaucoma treatment
US7331984B2 (en) 2001-08-28 2008-02-19 Glaukos Corporation Glaucoma stent for treating glaucoma and methods of use
US7163543B2 (en) * 2001-11-08 2007-01-16 Glaukos Corporation Combined treatment for cataract and glaucoma treatment
US7951155B2 (en) 2002-03-15 2011-05-31 Glaukos Corporation Combined treatment for cataract and glaucoma treatment
US9301875B2 (en) 2002-04-08 2016-04-05 Glaukos Corporation Ocular disorder treatment implants with multiple opening
US7972612B2 (en) * 2002-11-18 2011-07-05 Santen Pharmaceutical Co., Ltd. Remedy for glaucoma comprising Rho kinase inhibitor and β-blocker
JP2010508306A (ja) * 2006-10-31 2010-03-18 アルコン リサーチ， リミテッド 眼障害を治療するためのｐａｉ−１結合調節因子
US8506515B2 (en) 2006-11-10 2013-08-13 Glaukos Corporation Uveoscleral shunt and methods for implanting same
CZ2009190A3 (cs) * 2009-03-30 2010-10-13 Ústav experimentální medicíny AV CR, v.v.i Zpusob merení lokální toxicity látek a zarízení k jeho provádení
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
EP2755549A1 (de) 2011-09-13 2014-07-23 Dose Medical Corporation Intraokularer physiologischer sensor
EP2900680A4 (de) * 2012-09-28 2016-06-08 Univ Tufts Uridindiphosphatderivate, prodrugs, zusammensetzungen und verwendungen davon
US9730638B2 (en) 2013-03-13 2017-08-15 Glaukos Corporation Intraocular physiological sensor
WO2017040853A1 (en) 2015-09-02 2017-03-09 Glaukos Corporation Drug delivery implants with bi-directional delivery capacity
WO2017053885A1 (en) 2015-09-25 2017-03-30 Glaukos Corporation Punctal implants with controlled drug delivery features and methods of using same
AU2017252294B2 (en) 2016-04-20 2021-12-02 Dose Medical Corporation Bioresorbable ocular drug delivery device

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3306820A (en) * 1966-03-18 1967-02-28 Barnes Hind Pharm Inc Ophthalmic composition containing an anesthetic and fluorescein sodium
US4127674A (en) * 1977-03-21 1978-11-28 Allergan Pharmaceuticals, Inc. Method of treatment for glaucoma
JPS5495544A (en) * 1977-12-23 1979-07-28 Yamanouchi Pharmaceut Co Ltd Phenylethanolamine derivative and its preparation
CA1147342A (en) * 1977-10-12 1983-05-31 Kazuo Imai Process of producing novel phenylethanolamine derivatives
JPS5746946A (en) * 1980-07-09 1982-03-17 Sandoz Ag 3-aminopropoxyphenyl derivative, manufacture and medicine containing same
DE3125870C2 (de) * 1980-07-09 1994-09-15 William John Louis 3-Aminopropoxyphenyl Derivate, ihre Herstellung und sie enthaltende Arzneimittel
IE51421B1 (en) * 1980-08-01 1986-12-24 Smith & Nephew Ass Ophthalmic compositions containing triamterene
FR2640969B1 (de) * 1988-12-23 1991-11-22 Midy Spa
FR2642755B1 (de) * 1989-02-07 1993-11-05 Sanofi
EP0648118A1 (de) * 1992-07-02 1995-04-19 Telor Ophthalmic Pharmaceuticals, Inc. Verfahren und produkte zur behandlung von altersweitsichtigkeit

Also Published As

Publication number Publication date
DE69326610D1 (de) 1999-11-04
EP0642789B1 (de) 1999-09-29
RU94046143A (ru) 1996-09-27
BR9306399A (pt) 1998-09-15
CA2136321A1 (en) 1993-12-09
TW219930B (de) 1994-02-01
ES2137260T3 (es) 1999-12-16
KR100253515B1 (ko) 2000-05-01
HU9403350D0 (en) 1995-02-28
ATE185070T1 (de) 1999-10-15
RU2102069C1 (ru) 1998-01-20
EP0642789A1 (de) 1995-03-15
HUT71123A (en) 1995-11-28
BG99213A (bg) 1995-08-28
CN1080849A (zh) 1994-01-19
DE69326610T2 (de) 2000-06-08
US5663205A (en) 1997-09-02
EP0642789A4 (de) 1995-03-29
WO1993024121A1 (en) 1993-12-09

Similar Documents

Publication Publication Date Title
EP0642789B1 (de) Arzneimittel gegen glaukom
US10226420B2 (en) Methods of eye treatment using therapeutic compositions containing dipyridamole
US6403598B1 (en) Ophthalmic composition
US5527831A (en) Pharmaceutical composition for topical application to the eye for treating increased intraocular pressure
HEATH et al. Use of Phenylephrine Hydrochloride (Neo-Synephrine Hydrochloride®) in Ophthalmology
US5196449A (en) Methods and pharmaceutical compositions for the treatment of ophthalmic diseases
US5519030A (en) Method for prophylaxis and treatment of myopia
TW304879B (de)
Newsome Noninfectious ocular complications of AIDS
JP2741285B2 (ja) 緑内障治療剤
Moore 8 Chapter Anticholinergic Agents (Parasympatholytics)
CN116270442A (zh) 一种用于矫正近距离视力的眼用制剂
WO2023048174A1 (ja) 角膜疾患治療剤
Sampaolesi et al. Medical Therapy in Glaucoma
Gilger Il glaucoma nel cavallo
Michau How to diagnose and treat glaucoma in the horse.
CZ20002770A3 (cs) Oční prostředky